Radioisotope production heats up

Article

MDS Nordion has begun making commercial quantities of rhenium 186 (Re-186) and high-specific-activity lutetium 177 (Lu-177). Demand is growing for these radioisotopes for use in research aimed at developing new cancer therapies. Lu-177, a low-energy beta

MDS Nordion has begun making commercial quantities of rhenium 186 (Re-186) and high-specific-activity lutetium 177 (Lu-177). Demand is growing for these radioisotopes for use in research aimed at developing new cancer therapies. Lu-177, a low-energy beta emitter, shows promise against small tumors. It has a relatively long 6.65-day half-life, which allows more sophisticated procedures to be used for its purification and synthesis. The long half-life also makes Lu-177 easier to combine with biologically active compounds. Re-186 is being investigated for a range of radiotherapeutic applications. It is currently being used for pain palliation from cancerous metastases in bones. Both Lu-177 and Re-186 emit gamma radiation that enables imaging.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.